Home » Newsletters » BioWorld Science

BioWorld Science

May 20, 2022

View Archived Issues

New phospholipid anticancer target identified

Single-use digestive cartridge improves fat and nutrient absorption in a porcine SBS model

ROR2 CAR T cells exhibit cytotoxic effects against tumoral cells

CD70-CAR NK cells have cytotoxic effects against osteosarcoma

Auransa identifies new agents for bacterial and fungal infections

New CTP synthase 1 inhibitors discovered at Nimbus Clotho

Mount Sinai School of Medicine patents ATP6V1A gene expression enhancers

Spectrum Pharmaceuticals divulges G12C mutant GTPase KRAS inhibitors

Chulalongkorn University presents compounds for treating hepatitis B virus infections

Novel mouse models of RP59 retinal degeneration

HDAC6 inhibitor CKD-510 shows promise for the treatment of CMT1A

Preclinical studies of JAG-101, a gene therapy for type 1 galactosemia

Clearmind's MEAI shows suppressive effect on alcohol consumption in mice

ORT-247 demonstrates efficacy in preclinical models of CMT and ALS

Myrtelle enters licensing agreement with Rescue Hearing for gene therapy for genetic hearing loss

FDA grants orphan drug designation to XMT-2056 for gastric cancer

PostEra's AI approach to accelerate NIH-funded work for pandemic preparedness

Biomea nominates third-generation FLT3 inhibitor as IND candidate

Blue Water Vaccines collaborates with Instituto Butantan on universal influenza vaccine candidate

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...